L. Sacco Hospital (Vialba)
Milan, MI, 20157, Italy
NCT Number: NCT01042626
The purpose of this study is to assess if subjects with hyperparathyroidism with normal serum calcium levels have different responses in the calcium regulating hormonal handling compared to a) patients with primary hyperparathyroidism and high serum calcium levels; b) healthy subjects.
The differences will be evaluated with oral peptones load and subsequent blood samples collected every 15 minutes for two hours. Ionized calcium, phosphate, gastrin and PTH levels will be evaluated.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Milan, MI, 20157, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Enrolled subjects will receive 10 g Liebig meat extract diluted in 250ml of 0.9% saline
Time frame: 2 hours
Time frame: 2 hours
Time frame: 2 hours
Time frame: 2 hours
University of Eastern Piedmont
Other
Dissimilar PTH, Gastrin, and Ionized Calcium Response to Oral Peptones in Normocalcemic Primary Hyperparathyroidism, Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05152927
Adenoma, Calcium Metabolism Disorders
San Francisco, California, United States
View Trial DetailsNCT00001277
Calcium Metabolism Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Bethesda, Maryland, United States
View Trial DetailsNCT00744302
Calcinosis, Calcium Metabolism Disorders
Guangzhou, Guangdong, China
View Trial DetailsNCT00975000
Calcium Metabolism Disorders, Chronic Allograft Nephropathy
Phoenix, Arizona, United States
View Trial Details